Sign In
Buy EXEL
$51.60
+3.06 (+6.30%)
At Close: Jun 03, 2026
Exelixis, Inc. (NASDAQ:EXEL) to Post Q1 2020 Earnings of $0.12 Per Share, Oppenheimer Forecasts
05:42am, Thursday, 23'rd Apr 2020
Exelixis, Inc. (NASDAQ:EXEL) – Equities research analysts at Oppenheimer raised their Q1 2020 earnings estimates for shares of Exelixis in a research note issued on Monday, April 20th. Oppenheimer a
Biotech Stock Roundup: ALXN, MRNA Up on Coronavirus Treatment Updates, & More
02:30pm, Wednesday, 22'nd Apr 2020
The biotech sector is in focus with pipeline updates from companies evaluating treatments for the novel COVID-19.
